TP53 and mature T-cell and NK-cell non-Hodgkin lymphoma: We observed frequent mutations of epigenetic modifiers, members of the JAK/STAT signaling cascade, and TP53, and recurrent genomic alterations, similar to those described in PTCL arising in immunocompetent individuals.